A Matter of Difference: Laytons in the ECJ

L
Laytons
Contributor
Laytons
Astex Therapeutics Limited sought to register "ASTEX TECHNOLOGY" included in a figurative mark for pharmaceuticals.
UK Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Astex Therapeutics Limited sought to register "ASTEX TECHNOLOGY" included in a figurative mark for pharmaceuticals. A company called Protec, which for some reason had registered the word "ASTEX" for insecticide for killing dust mites, succeeded in opposing the registration.

Laytons were brought in to argue the appeal. The argument for the validity of the new mark was that the nature of the goods was different: one was for promoting human well-being; the other was for exterminating living creatures.

Further, if the goods were displayed in the same pharmacy, the likelihood of imperfect recollection would be reduced.

The Court decided that since both these products could be of interest to persons suffering from respiratory problems, it was considered that the relevant public were likely to believe that the goods bearing the respective signs were from the same or similar sources.

In summary, a higher degree of similarity of trade marks may prevail over a low degree of similarity of goods.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

A Matter of Difference: Laytons in the ECJ

UK Intellectual Property
Contributor
Laytons
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More